In Collaboration With JScreen, Cancer Warrior Lainie Jones Advocates for Genetic Testing

ATLANTA, GA / ACCESSWIRE / August 22, 2023 / The story of Lainie Jones, a cancer survivor from Fort Lauderdale, Florida, transcends typical narratives about disease. Before the age of 40, she courageously faced down five different forms of cancer caused by Li-Fraumeni Syndrome, an inherited predisposition to a wide range of cancers. Her experience led her to fight not just for her own life, but also for the lives of others.

Cancer Warrior Lainie Jones Advocates for Genetic Testing With JScreen, Non-Profit Organization
Lainie battled five cancers before 40, including adrenal as a baby and breast cancer at 24. In collaboration with JScreen, she aims to spread awareness about genetic testing.

Jones is renowned for her resilience, buoyant humor, and indomitable optimism, traits that make her a beacon of hope for those wrestling with their own health challenges. With a life so touched by cancer, Jones has dedicated herself to educating others about the power of genetic testing for early detection and risk assessment of hereditary diseases.

This isn’t just a cause for Jones, it’s personal. She recognizes that “knowledge brings options” and posits that awareness of one’s genetic predisposition can help individuals shape their lifestyles and health choices to reduce specific risk factors.

Jones’s advocacy is rooted in her personal experience. She has walked the arduous path of illness and emerged as a testament to the resilience of the human spirit. She feels blessed that she regained control of her health largely due to proactive genetic testing and passionately shares her journey to inspire others to do the same.

In collaboration with JScreen, a national non-profit organization that provides genetic screening and confidential support from expert genetic counselors, Lainie Jones’ mission to spread awareness about genetic testing has taken a concrete form. She hopes that by sharing the resources available through organizations like JScreen, others can avoid the uncertainty she faced battling cancer multiple times.

Jones expresses, “If I had known about organizations like JScreen earlier, it would have been a game-changer in my health journey. I am driven to advocate for genetic testing, aiming to inspire early detection and help as many people as possible.”

Despite her trials, Jones’ story is not one of defeat but of unwavering resilience, infectious joy, and devoted advocacy. Every day, she uses her experiences to educate, inspire, and empower others to take charge of their health, underscoring the transformative potential of genetic testing in the fight against cancer.

JScreen is a national non-profit public health initiative dedicated to preventing genetic diseases. Headquartered in Atlanta at Emory University School of Medicine, the JScreen initiative provides convenient at-home access to cutting-edge genetic testing technology, patient education and genetic counseling services. JScreen believes the combination of education, access to premier gene screening technologies and personalized, confidential support are the keys to preventing these devastating diseases.

Contact Information

Stacey Bender
PR Representative
sbender@bendergrouppr.com
9736501218

Related Images

Cancer Warrior Lainie Jones Advocates for Genetic Testing With JScreen, Non-Profit Organization
Lainie battled five cancers before 40, including adrenal as a baby and breast cancer at 24. In collaboration with JScreen, she aims to spread awareness about genetic testing.
JScreen, a National Non-Profit Organization
JScreen is a national non-profit public health initiative dedicated to preventing genetic diseases. The initiative provides convenient at-home access to cutting-edge genetic testing technology, patient education and genetic counseling services.

SOURCE: JScreen

View source version on accesswire.com:
https://www.accesswire.com/776034/In-Collaboration-With-JScreen-Cancer-Warrior-Lainie-Jones-Advocates-for-Genetic-Testing

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

12 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

15 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

15 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

15 hours ago